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Abstract: Skeletal muscle fibres are unique cells in large animals, often composed of thousands
of post-mitotic nuclei. Following skeletal muscle damage, resident stem cells, called satellite cells,
commit to myogenic differentiation and migrate to carry out repair. Satellite stem cells migrate
on muscle fibres through amoeboid movement, which relies on dynamic cell membrane extension
and retraction (blebbing). It is not known whether blebbing is due to the intrinsic properties of
satellite cells, or induced by features of the myofibre surface. Here, we determined the influence
of the muscle fibre matrix on two important features of muscle regeneration: the ability to migrate
and to differentiate down a myogenic lineage. We show that the muscle fibre is able to induce
amoeboid movement in non-muscle stem cells and non-stem cells. Secondly, we show that prolonged
co-culture on myofibres caused amniotic fluid stem cells and breast cancer cells to express MyoD,
a key myogenic determinant. Finally, we show that amniotic fluid stem cells co-cultured on myofibres
are able to fuse and make myotubes that express Myosin Heavy Chain.
Keywords: stem cell; muscle; myofibre; adipose-derived stem cell; dental pulp; amniotic fluid stem
cells; reprogramming; migration; amoeboid
1. Introduction
Skeletal muscle is imbued with a stem cell resident population called satellite cells (SC), which
have a huge capacity to regenerate damaged tissue [1]. Transplantation of a single muscle fibre
containing a few SC is able to generate tens of thousands of cells in a matter of weeks [1]. SC also
have remarkable migratory properties, demonstrated by their ability to move from undamaged
muscles, into areas that require repair [2,3]. However, in a disease context, the ability of SC to
promote repair is severely hampered, for a number of reasons. Firstly, it is believed that repeated
rounds of degeneration/regeneration, leads to an exhaustion of the stem cell pool [4]. Secondly,
the development of a fibrotic and adipogenic environment impacts on not only SC differentiation,
but also on their ability to migrate [5]. A number of studies have demonstrated the importance of
migration in the muscle repair process. Clinical interventions based on myoblast injections have failed,
since cells are rarely dispersed more than 200 µm from the site of application [6–8]. Therefore, there is
an unmet need to generate cells with the appropriate ability to migrate, thus facilitating clinical skeletal
muscle generation.
We have previously shown that skeletal muscle fibres promote SC to migrate, using a distinctive
amoeboid-based mechanism in which cells extend and retract numerous membrane protrusions,
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often one tenth of the diameter of the cells, within a couple of minutes [9,10]. Amoeboid-based
migration is thought to develop simple focal adhesions (reviewed by [11]), and is believed to generate
traction through multiple blebs, all of which generate small amounts of pull [12]. The matrix appears
to be the defining factor governing how SC migrate, since placing them on plastic surfaces results in
the formation of lamellipodia [10].
The surface matrix not only governs the mechanism of migration, but also directs the fate of
stem cells. Engler and colleagues showed that the matrix elasticity directed the specification of stem
cells into either neural, myogenic, or osteogenic lineages [13]. They demonstrated that the stiffness,
over two orders of magnitude (ranging from 1 to 100 kPa), regulated the differentiation of human
mesenchymal stem cells, into either neurons, skeletal muscle, or bone [13]. Subsequent work showed
that changes in tissue stiffness (induced, for example, through fibrosis) had a major impact on the
self-renewing properties of SC [14].
Our previous work has shown that SC adopted amoeboid-based migration when positioned on
muscle fibres. However, it is not known whether this property is solely due to features of SC, or those
of the muscle fibre. Secondly, it is not known whether the amoeboid-based migration is an option
available to all stem cells, or even somatic cells, when they encounter the muscle fibre matrix. Lastly,
it remains to be determined whether the surface of a muscle fibre could influence the fate of, not only
stem cells, but also non-stem cells.
In this study, we examined the impact of the muscle fibre matrix on, firstly, the migratory
properties and, secondly, the ability to promote a myogenic fate on three well-defined stem cell
populations, as well as one non-stem cell line. We chose adipose-derived mesenchymal stem cells
(ADMSC), dental pulp stem cells (DP), and amniotic fluid stem cells (AFS) for our investigation,
as these have been extensively characterised for multi-potency, are relatively easy to culture, and are in
advanced stages of development as therapeutic agents for human diseases [15–19]. The MDA-MB-231
breast cancer line (MDA) was chosen as a non-stem cell source as it is extremely easy to propagate
and is well characterised. Here, we show that all three of the stem cell lines and the one non-stem
cell line, migrated by the mesenchymal mechanism on plastic. However, once they were seeded on
mouse muscle fibres, they adopted amoeboid-based migration. We also show that all of the cells
which adopted amoeboid-based migration were underpinned by the same molecular mechanisms;
ROCK (Rho-associated protein kinase) activity promoted blebbing, whereas Arp2/3 inhibited blebbing.
Most remarkably, we show that simple contact of AFS and MDA at the surface of a muscle fibre was
sufficient for cells to induce the expression of the key myogenic determinant, MyoD. Finally, we show
that AFS cells grown on myofibres are able to form myotubes.
2. Material and Methods
2.1. Ethical Approval
The experiments were performed under a project license from the United Kingdom (UK) Home
Office, in agreement with the Animals (Scientific Procedures) Act 1986.
2.2. Animal Maintenance
Healthy male wild-type C57BL/6 mice (3–5 month-old) were maintained in accordance with the
Animals (Scientific Procedures) Act 1986 (UK), and were approved by the University of Reading in
the Biological Resource Unit of Reading University. Mice were housed under standard environmental
conditions (20–22 ◦C, 12–12 h light–dark cycle), and were provided with food (standard pelleted diet)
and water ad libitum.
2.3. Cell Lines and Cultures
Cells transplanted onto mouse myofibres were identified using GFP-labelled cells. Human
adipose-derived mesenchymal stem cells (ADMSC) (Life Technologies 510070, Carlsbad, CA, USA)
were grown in MesenPro RS™ medium, supplemented with 1% penicillin streptomycin (Thermo Fisher
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Scientific, Carlsbad, CA, USA). Human amniotic fluid stem cells (AFS) (GFP+) (Gift from
Prof. Paolo De Coppi, University College London) were grown in Minimum Essential Medium (alpha
modification) (α-MEM), 15% foetal bovine serum (FBS), 1% L-glutamine, and 1% penicillin streptomycin
(Thermo Fisher Scientific) supplemented with 20% Chang B/C media (Irvine Scientific, Santa Ana, CA,
USA). Rat dental pulp stem cells (DP) (GFP+; Isolated from SD-Tg(CAG-EGFP)CZ-004OS6 rats)
(Gift from Professor Bing Song, Cardiff, UK) [20] were cultivated in α-MEM, 20% FBS, 1% L-glutamine,
1% penicillin-streptomycin (Thermo Fisher Scientific), and 100 mM L-ascorbic acid (Sigma-Aldrich,
Saint Louis, MO, USA). A MDA-MB-231 (GFP+) breast adenocarcinoma cell line (MDA) (Gift from
Prof. P. Dash, University of Reading) was cultivated in DMEM containing GlutaMAX, supplemented
with 10% FBS, 1% L-glutamine, and 1% penicillin streptomycin (Thermo Fisher Scientific).
2.4. Single Myofibre Isolation and Culture
Animals were humanely sacrificed via Schedule 1 killing and myofibres were isolated from
the Extensor digitorum longus (EDL) muscle of the hindlimb, as previously described [21,22]. Briefly,
the EDL was carefully dissected and myofibres were dissociated with 0.2% type I collagenase in
Dulbecco’s modified Eagle medium (DMEM) at 37 ◦C in 5% CO2. Using tapered glass pipettes,
individual myofibres were liberated and placed into a suspension culture with single fibre culture
medium (SFCM) consisting of DMEM containing GlutaMAXm supplemented with 10% horse
serum, 1% penicillin/streptomycin, and 5% chick embryo extract, and were incubated at 37 ◦C
in 5% CO2. Cultures consisted of myofibres which had been isolated from three to nine animals, and
were combined in order to maintain consistency and homogeneity among experimental conditions.
Experimental time-zero (T0) began at the point of myofibre isolation. A total of 250,000 cells of each
cell type were seeded into separate single myofibre suspension cultures for 2 h (T0–T2), at 37 ◦C in
5% CO2, allowing for cell-myofibre adherence. At T2, myofibres (with non-muscle cells attached) were
transferred to new culture wells with fresh SFCM.
2.5. Cytoskeletal Inhibitor Preparation
The ROCK inhibitor Y-27632 (Abcam 120129, Cambridge, UK) was used at a concentration
of 10 µg/mL. The Arp2/3 inhibitor CK666 (Abcam 141231) was used at 150 µM. The required
concentrations of inhibitors were made up in SFCM.
2.6. Time-Lapse Microscopy
Myofibre cultures were examined using phase-contrast microscopy with time-lapse capabilities,
as previously described [9], but with the following differences: time-lapse video was captured at
10× magnification, at a rate of one frame per 15 min over a 12-h period (T2–T14), prior to endogenous
satellite stem cell emergence and proliferation [23].
2.7. Myotube Formation
Myofibres were cultured with or without transplanted non-muscle cell types, at 37 ◦C in 5% CO2
for up to 10 days (T240), and the fresh media (SFCM) was changed every three days. Cells were
dissociated from myofibres with TrypLE™ Select Enzyme (Thermo Fisher Scientific), seeded onto
cell culture-treated glass cover slips, and grown in cell-specific (AFS or MDA) growth medium (GM).
Once confluent, GM was exchanged for a myogenic differentiation medium consisting of DMEM with
GlutaMAX, containing 2% horse serum and 1% penicillin/streptomycin (Thermo Fisher Scientific),
and this was cultured for up to 14 days before fixation in 4% paraformaldehyde (PFA) in phosphate
buffered saline (PBS) for 15 min, after which it was stored in PBS.
2.8. Immunocytochemistry
Immunocytochemistry protocols for examining resident and transplanted non-muscle cells on
single myofibres were carried out as described previously [23]. Briefly, myofibres (or cell/ myotube
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cultures) were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) (PFA) for 10 min,
and were washed three times in PBS before permeabilisation in a buffer solution, consisting of
20 mM HEPES, 300 mM sucrose, 50 mM NaCl, 3 mM MgCl2, 0.5% Triton X-100, and 0.05% sodium
azide (pH 7), at 4 ◦C for 15 min. Following this, non-specific binding was blocked using a wash
buffer with 5% FBS, in PBS containing 0.01% Triton X-100 and 200 mg sodium azide, for 30 min at
room temperature. The primary antibodies used in this study included: polyclonal rabbit anti-MyoD
(Santa Cruz Biotechnology, Dallas, TX, USA), sc-760, 1:200), monoclonal mouse anti-actin (alpha smooth
muscle) (Sigma-Aldrich, A2547, 1:200), polyclonal goat anti-green fluorescent protein (GFP) (biotin)
(Abcam, ab6658, 1:200), and monoclonal mouse anti-Myosin Heavy Chain (MHC) (Developmental
Studies Hybridoma Bank (DSHB) clone A4.1025, 1:1). Primary antibodies were visualised using the
following secondary antibodies: Alexa Fluor goat anti-mouse 488 (Invitrogen, Carlsbad, CA, USA,
A11029), Alexa Fluor goat anti-mouse 594 (Invitrogen, A11032), Alexa Fluor goat anti-rabbit 594
(Invitrogen, A11037), and Alexa Fluor 488 Streptavidin (Molecular Probes, Carlsbad, CA, USA,
S-11223). Secondary antibodies were used at a scale of 1:200. To visualise non-GFP hADMSCs,
a PKH26 red fluorescent membrane labelling kit was used, according to the manufacturer’s instructions
(Sigma-Aldrich, PKH26GL). Myofibres were mounted in fluorescent mounting medium (DAKO)
containing 5 µg/mL 4′,6-diamidino-2-phenylindole-(DAPI) for nuclear visualisation.
2.9. Fluorescence Microscopy
Mounted myofibres were visualised using a Zeiss AxioImager fluorescent microscope and images
were captured using an Axiocam digital camera system, before being analysed using Axiovision image
analysis software (version 4.9.1) (Carl Zeiss AG, Oberkochen, Germany).
2.10. Scanning Electron Microscopy
Scanning electron microscopy (SEM) of single myofibres was carried out as previously
described [9]. Briefly, single myofibres were fixed in 4% PFA/PBS for 10 min and dehydrated through
a series of 15-min ethanol incubations (30%, 50%, 70%, 80%, 90%, and 100% ethanol solutions).
Following this, myofibres were transferred to a critical point drier (Balzers CPD 030) (Oerlikon Balzers,
Balzers, Liechtenstein) and further dehydrated using liquid carbon dioxide. Using micro forceps,
dried myofibres were transferred to SEM sample stubs, and were gold-coated using an Edwards S150B
sputter-coater (HHV, Crawley, UK), before being visualised using an FEI 600F SEM (FEI, Hillsboro,
OR, USA) and supporting analysis software for image generation.
2.11. Image and Movie Analysis
All image analysis was carried out using the freeware package ImageJ (version 1.4.3) (Bethesda,
MA, USA). Individual resident and non-muscle cells were manually tracked using the MTrackJ plugin.
Bleb numbers and dimensions were quantified manually on SEM images of cells, using the cell counter
and length measurement tools. Blebs were counted across the visible extent of the cell surface in each
SEM image [9]. Measurements consisted of the bleb height from the individual point of protrusion,
outwards from the cell surface to the boundary of each single bleb, as well as the measurement across
each bleb to obtain the width. Cell morphology analysis of resident satellite cells and non-muscle
cell types on myofibres, as well as an investigation into the effects of differing inhibitor treatments
and the capacity for myogenic differentiation of non-muscle cells into myotubes, were all manually
assessed using quantification of live images through the Zeiss Axio Imager microscope (Carl Zeiss AG,
Oberkochen, Germany)and Axiovision digital camera system (Carl Zeiss AG, Oberkochen, Germany).
The percentage of myotubes produced by non-muscle cells, was quantified as the number of nuclei
located within myosin-positive cell structures, as a proportion of the total nuclei.
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2.12. Statistical Analysis
Statistical analysis was performed using Student’s t-tests, unless otherwise indicated, with
significance levels of * p < 0.05, ** p < 0.01, and *** p < 0.001, using GraphPad Prism statistical
software (Version 6) (La Jolla, CA, USA). All data are presented as mean ± standard error of the mean.
3. Results
Skeletal muscle stem cells display three interesting properties when examined on muscle fibres,
their native surface: (1) cells are round in shape rather than flat, with a broad leading edge; (2) migrate
at very high speeds; and (3) readily activate along the skeletal muscle differentiation pathway. Here,
we examined whether these properties are due to a feature of the muscle fibre, or intrinsic to the SC.
Firstly, we characterised the influence of the matrix on the mechanisms used for cell migration.
To that end, we compared the cell morphology of the differing cells on plastic versus muscle fibres.
Our results show that, like most SC, ADMSC, AFS, and DP stem cells on plastic, took on a flattened
elongated form (mesenchymal) (Figure 1(A, C1–C3)). In contrast to this, the majority of MDA cells were
rounded (Figure 1(A, C4)). We then compared this profile to the same cells on the surface of a muscle
fibre. As previously described, we found that all SC assumed a rounded morphology (Figure 1B) [10].
Surprisingly, there was a significant increase in the proportion of rounded morphologies in all of the
other cell types examined, when they were juxtapositioned on muscle fibres (Figure 1(B, C5–C8)). These
results show that the rounded morphology adopted by muscle stem cells, are not a unique intrinsic
feature. Instead, all cells tested, either stem or non-stem, assume this form when they encounter the
surface of a muscle fibre.
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Figure 1. The skeletal myofibre matrix influences non-muscle cellular morphologies. (A) Frequencies
of morphologies adopted by satellite cells (SC, n = 21 cells examined), adipose-derived mesenchymal
stem cells (ADMSC, n = 52), amniotic fluid stem cells (AFS, n = 32), dental pulp stem cells (DP, n = 26)
and MDA-MB-231 breast cancer cells (MDA, n = 31), on plastic; (B) Cell morphologies displayed by
SC (n = 45 myofibres examined), ADMSC (n = 34), AFS (n = 35), DP (n = 26), and MDA (n = 43),
on myofibres; (C) Representative m rphologies of non-muscle cells observed on plastic (1–4) and on
myofibres (5–8). Scale 50 µm. Individual Student’s t-tests showed statistical significance between
‘Round’ and ‘Elongated’ morphologies in each cell type, ** p < 0.01, *** p < 0.001.
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Next, we examined the influence of the matrix on cell migration speed, having previously
shown that SC on muscle fibres travelled at high velocities, when compared to their movement on
plastic [9,10]. In this study, we demonstrated that SC on myofibres moved at a higher speed than on
plastic, thus reproducing our previous findings (Figure 2A) [10]. The ability of the myofibre surface to
support faster movement than that of a plastic surface, was also found with DP and MDA (Figure 2A).
In contrast, ADMSC and AFS cells showed a significant decrease in migration speed on muscle fibres,
when compared to plastic (Figure 2A). Next, we examined the migration speeds of the differing cell
morphologies on muscle fibres. We found that for ADMSC, DP, and MDA cells, migration speed was
not influenced by the structure of the cell (Figure 2B). Surprisingly, we found that rounded AFS cells
on muscle fibres moved slower than those with elongated characteristics (Figure 2B).
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Figure 2. The skeletal muscle myofibre impacts on the migration speed of co-cultured non-muscle
cells. (A) Cell migration speed comparison between plastic and myofibre substrates; (B) Migration
speeds of differing morphologies of resident and non-muscle cells on myofibres. In all conditions
n ≥ 15 myofibres examined. Individual Student’s t-tests, ** p < 0.01, *** p < 0.001.
We have previously shown that the activity of ROCK was a key determinant of the
rounded/blebbing satellite cell morphology, when placed on muscle fibres [9,10]. In contrast, much
work has shown that the leading edge of mesenchymal cells required the activity of Arp2/3, in order
to promote the formation of lamellipodia [24]. Here, we examined the consequences of inhibiting
ROCK and Arp2/3 with their specific inhibitors, Y-27632 and CK666, respectively, on cell migration
velocity and morphology [25,26]. We found that inhibi ing ROCK decreased the migratory speed of all
cells examined, whe compared to mock treated e ls (solvent only) (Figure 3A). In contrast, inhibiting
Arp2/3 activity only decreased the migration speed of ADMSCs (Figure 3A). We also examined the
influence of the inhibitors on cell morphology. For all cell types, we found that inhibition of ROCK
promoted the abundance of elongated cells, whereas CK666 increased the proportion of rounded cells
(Figure 3B). These results show that molecular mechanisms regulating migration, are conserved in a
diverse group of cells.
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(B) Effect of inhibiting ROCK (Y-27632) and Arp2/3 (CK666) on cell morphology frequencies. In all
conditions n ≥ 15 myofibres examined. One-way ANOVA (A), individual Student’s t-tests (B),
* p < 0.05, ** p < 0.01, *** p < 0.001. In (B) statistical differences indicated between proportion of rounded
and elongated cell numbers.
Next, we examined non-muscle stem cells f r the pres nce of blebs, a key feature of amoeboid
migration. We have previou ly s own that SC on myofibres use the oeboid mechanism for cell
movement, w ich manifes s as a huge number of hi hly dynamic plasma membrane protru io s [10].
We found that, in all cell types examined, decreasing the Arp2/3 activity resulted in an increase in the
number of blebs on t surface of cells located on muscle fibres (Figure 4A, C–F and K–N). How ver,
the dimensions of the blebs in terms of their heights and widths, were not affected to any great degree,
with Arp2/3 inhibition increasing only the width of blebs on the surface of MDA cells (Figure 4B).
As previously demonstrated, inhibiting ROCK resulted in elongated cells that did not contain any
blebs (Figure 4A,G–J).
These results show that the mechanisms underpinning blebbing are highly conserved, with ROCK
activity responsible for maintaining a rounded profile and Arp2/3 controlling lamellipodia formation.
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Finally, we examined whether the myofibre surface encourages cells to adopt a myogenic fate.
To that end, we seeded GFP+ non-muscle stem cells, as well as GFP+ MDA cells, onto freshly isolated
muscle fibres, and profiled the expression of markers for muscle precursors (Pax7), committed muscle
cells (MyoD), and differentiating muscle cells (Myogenin) [23]. Resident SC (non-GFP) expressed
Pax7 on freshly isolated cells and continued to do so until 48 h, after which i s presence gradually
decreased, which is in agreement with previous studies [23,27]. MyoD is not express d n freshly
isolated SC, but is known to become detectable 24 h after activation [23]. Our data, in concordance with
the literature, showed that MyoD was present in over 80% of cases after 24 h of culture (Figure 5A).
Between 48 and 120 h of culture, all SC on myofibres expressed MyoD, which then decreased by 240 h,
which has previously been shown to be replaced by the expression of Myogenin (Figure 5A) [23].
None of the non-muscle cells expressed Pax7 at any time point up to 240 h of culture. Non-muscle
stem cells initially adopted rounded morphologies, up to approximately 48 h after seeding on freshly
isolated fibres, but then took on one of two morphologies. ADMSC and DP cells gradually elongated,
especially around the circumferenc of he fibres, and thereafter caused constrictions (Figure 5B,C).
By 72 h, there were no normal elongated fibres in the presence of ADMSC and DP cells, with the vast
majority either curled into balls or hyper-contracted, both of which signify myofibre damage.
In contrast, AFS and MDA maintained a rounded morphology and proliferated profusely
(Figure 5D,E). Of significance was the finding that by 240 h, approximately 50% of AFS and MDA cells
robustly expressed MyoD.
To investigate further, the myogenic differentiation potential of the non-muscle cells, as observed
with dissociated SC in previous studies [23], and their ability to form myotube structures following
enzymatic dissociation from the myofibres, was determined. Our results showed that AFS cells that had
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been dissociated from myofibres, fused to create elongated myotubes, indicated by myotube formation
with the co-expression of GFP+ and MHC, a key to the contractile protein of muscle (Figure 5F).
However, MDA cells that had also been detached from myofibres after 240 h of culture, failed to
express MHC, and showed no fusion events. Instead, they proliferated, producing multiple cell layers
(Figure 5H). Approximately 8% of all the AFS cells expressed MHC (Figure 5H) and formed cells with
1.5 nuclei (Figure 5I). Notably, no myogenic differentiation characteristics were observed in MDA or
AFS cells, which had not previously been in contact with myofibres.
These results show that the myofibre surface is unable to promote the expression of a marker of
muscle precursor cells (Pax7). However, prolonged culture of one stem cell (AFS) and remarkably, one
somatic cancer cell (MDA), resulted in the robust expression of a marker of committed muscle cells,
MyoD. Additionally, AFS cells cultured for prolonged periods with isolated myofibres, are able to
form myotubes.
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Figure 5. Induction of MyoD expression in AFS and MDA cells after prolonged culture on mouse
myofibres. (A) Temporal profiling of non-resident cells on myofibres for MyoD expression; (B) ADMSC
identified by GFP expression, constricting myofibre at T24; (C) DP cell distorting myofibre at T24;
(D) AFS cell at T240 showing nuclear expression of MyoD co-localising with DAPI (indicated by
magent arrow); (E) MDA cell at T240 showing nuclear expressi f yoD co-localising with
DAPI (indicated by magenta ar ow); (F) AFS cells, i ifi FP expre sion, co-localising with
myosin, fused to form elongated myotube str ct eads); (G) MDA cells co-cultured with
myofibres failed to initiate myosin expression; (H) Quantification of GFP+ cells expressing myosin;
(I) Number of nuclei per cell GFP+ expressing myosin. Scale 10 µm (B–E), and 100 µm (F, H). In (A–E),
n ≥ 12 myofibres examined.
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4. Discussion
The development of a source of muscle cells has huge clinical implications. Muscle is lost in a
large number of diseases such as Duchenne Muscular Dystrophy and Spinal Muscular Atrophy, but
is also a societal problem, as wasting occurs in a large proportion of the elderly who suffer from a
condition called sarcopenia [28]. Therefore, any means of generating muscle would potentially be of
great therapeutic value.
Previous work has shown that matrix elasticity has profound effects on cell fate, with stiff surfaces
promoting the formation of bone, medium stiffness inducing muscle, and soft surfaces allowing
the formation of neural tissues [13]. Here, we investigated the effect of the muscle fibre surface on
stem cell migration and differentiation. We have previously shown that the muscle fibre supports
a distinct form of movement, called amoeboid-based migration. Here, we show that three stem cell
types, and one non-stem cell line, adopted amoeboid-based migration when seeded onto muscle fibres.
Furthermore, they developed blebs, which made them essentially indistinguishable from resident stem
cells. However, it is noteworthy that an adoption of amoeboid-based migration for non-muscle cells
was not always accompanied by an increase in migration speed. It was previously proposed that rapid
movement based on bleb-based migration, was partly due to the simplicity of the focal adhesions
between the cells and the matrix, with less time being needed to assemble and disassemble these
structures [29]. However, our results show that blebbing does not always result in increased migration,
possibly due to a mis-match in the molecules needed for effective focal adhesion formation. We suggest
that non-muscle cells and satellite cells form different focal adhesions with the muscle fibre, possibly
linked to their developmental history. The concept of developmental history regulating cell behaviour
is well mapped in muscle, where it even segregates the properties of muscle stem cells [29]. Despite
differing profiles of migration speeds, we show that the cell morphology adopted by non-muscle cells
on fibres is regulated by the same molecular pathways. Elegant work by the Marshall lab have shown
that blebbing and lamellipodia-based mechanisms, act in an antagonistic fashion with Rho, through
ROCK supporting the former, and Rac, via WAVE2, promoting the latter [30]. Here, we show that this
relationship was conserved in the three differing stem cells and the one non-stem cell.
Our work sheds new light on a possible injurious role of ADMSC in chronic muscle
degeneration/regeneration. Accumulation of fat tissue is a key feature of this condition, for example,
in Duchenne Muscular Dystrophy, and is believed to hinder the activity of SC. [31,32]. However,
our work reveals a more direct property of ADMSC that would contribute to muscle pathology, based
on our finding that they induce fibre hyper-contraction. We were unable to find any live muscle fibres
that had been co-cultured with ADMSC after three days in culture. In contrast, the fibres with the
presence of other cells (e.g., AFS) are viable for a minimum of 10 days. Therefore, unregulated activity
of ADMSC may contribute to muscle pathology by inducing myofibre death.
The most intriguing aspect of our work is the finding that AFS and MDA cells adopted a myogenic
fate, as assessed by MyoD expression, and that AFS cells tfuse into MHC+ myotubes. Importantly,
we found that they developed this state without having first induced the expression of Pax7. This is
significant, as it implies that the cells are not deploying a molecular programme that is used during
normal development [33]. The expression of MyoD, but not Pax7, in adult cells has been interpreted to
indicate a state in which the only option is terminal differentiation, without a possibility of reverting
to a stem cell state [23]. This has major implications for future exploitation of our findings, as they
could only be used to carry out immediate repair of damaged tissue, but the cells themselves could
not be a reservoir for future rounds of muscle regeneration.
One major outcome of our work is that it shows that there is no necessity for using stem cells in
order to generate muscle cells. Stem cells are associated with issues related to ethics and specialised
isolation techniques [34]. However, we have shown that a rapidly growing non-muscle stem cell can
be converted at relatively highly frequency into cells that express MyoD. Importantly, as an extension
to this key finding, further investigation into the myogenic differentiation potential revealed that AFS
cells, but not the non-stem cell, were directed through the exposure to the muscle environment, to form
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myotube structures, reinforcing the potential therapeutic value of AFS cells. Therefore, we have further
established the influence that the microenvironment or matrix has on regenerative processes, such as
cell differentiation and fusion.
There are two major issues that we will resolve in future experiments, to determine the full
potential of our finding. Firstly, it would be ideal to minimise the use of a large number of small
animals for scale-up as a source of muscle matrix. To that end, we envisage using de-cellularised
muscle from bigger (commercial) species (bovine), which can be generated in large quantities [35].
A number of advances have recently been made in creating materials often involving electrospinning,
that direct either a partial or complete move away from man/animal tissues for use in muscle-based
pathologies [36]. Many of the artificial materials support the differentiation and fusion of muscle stem
cells, into ordered myotubes [37]. However, none, to our knowledge, have investigated the movement
of SC in these matrixes, nor whether they occur in an amoeboid manner, let alone if their physical
properties support myogenic conversion of non-muscle cells. Investigating migratory mechanisms
and myogenic reprogramming by de-cellularised muscle and artificial muscle-like materials, will be
the focus of our future investigations.
Secondly, it will be essential to characterise the key properties of myogenic cells induced by the
co-culture method deployed here. To that end, it will be necessary to determine whether these cells can
promote muscle regeneration. We will address this line of investigation by developing GFP-labelled
MyoD+ cells from both AFS and MDA, and injecting them into immunocompromised mice which
have undergone cardiotoxin-induced muscle degeneration, before assessing the development of GFP+
muscle fibres [38].
5. Conclusions
We show that the muscle fibre matrix is able to promote non-muscle cell movement based
on amoeboid-based migration. Both non-muscle stem cells and non-stem cells are amenable
to myofibre-based reprogramming of migration mechanisms. We also show that cell fate is
reprogrammable by the muscle fibre matrix, resulting in a robust expression of the myogenic marker
MyoD, in both AFS and MDA cells. Moreover, we demonstrate a greater myogenic differentiation
capability of AFS cells, following dissociation from the myofibre matrix, leading to myosin expression
and myotube formation.
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